VICTREX PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,284 GBX | -0.47% |
|
+0.78% | -15.64% |
| May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
| Apr. 19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Presentation Operator MessageOperator (Operator)Hello and welcome to the Victrex Q3 IMS 2019 c...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Victrex plc is a United Kingdom-based holding company. The principal activity of the Company is the manufacture and sale of high-performance polymers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers and selects semi-finished and finished parts. The Company operates through two segments: Sustainable Solutions and Medical. The Sustainable Solutions segment focuses on its energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Companyâs subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited and Juvora Limited.
Sector
Specialty Chemicals
Calendar
2024-05-12
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
12.84
GBP
Average target price
15
GBP
Spread / Average Target
+16.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.64% | 1.4B | |
| +1.61% | 49.2B | |
| +16.33% | 41.24B | |
| +18.68% | 25.89B | |
| +12.78% | 19.81B | |
| +0.85% | 17.48B | |
| -21.87% | 15.86B | |
| +2.32% | 15.35B | |
| -10.29% | 15.23B | |
| -22.30% | 13.36B |
- Stock Market
- Equities
- VCT Stock
- News Victrex plc
- Transcript : Victrex plc, Q3 2019 Interim Management Statement Call, Jul 25, 2019
